1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow ADHD, Predominantly Inattentive Type: new trials by email Literature Review of ADHD, Predominantly Inattentive Type trials Research Report on ADHD, Predominantly Inattentive Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years. Communication Strategy for Side Effect Counseling in ADHD Treatment - Attention Deficit Disorder, Attention Deficit Disorder (ADD) | Not applicable | Not yet recruiting | St. Antonius Hospital | 130 | 2025-01-25 | 2025-01-28 |
| Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects Metadoxine extended release, Placebo - ADHD, Predominantly Inattentive Type | Phase 2 | Completed | Alcobra Ltd. | 83 | 2014-08-01 | 2015-03-04 |
Attention Deficit Disorder with Hyperactivity (2) · Drug-Related Side Effects and Adverse Reactions (1) · Medication Adherence (1) · Patient Compliance (1) · Spasm (1)
Attention Deficit and Disruptive Behavior Disorders (2) · Mental Disorders (2) · Neurodevelopmental Disorders (2) · Behavior (1) · Chemically-Induced Disorders (1) · Health Behavior (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Patient Acceptance of Health Care (1) · Signs and Symptoms (1) · Treatment Adherence and Compliance (1)
Sugars (1)
Alcobra Ltd. (1) · St. Antonius Hospital (1)
Israel (1)
Arine Vlieger, MD, PhD (1) · Iris Manor, MD (1)